AIM RX 3PL, LLC Clindamycin Import Data from India (DGFT 2022–2026)

Q: Who are the top buyers of Clindamycin from India and how much does AIM RX 3PL, LLC import?

India exports Clindamycin to 1,029 buyers globally worth $31.6M. AIM RX 3PL, LLC imports $2.4M (3.6% market share) with 80 shipments from UNITED STATES.

Q: What is the average order value for AIM RX 3PL, LLC's Clindamycin imports?

AIM RX 3PL, LLC's average Clindamycin order value is $30.4K per consignment, based on 80 shipments totaling $2.4M.

Q: Who supplies Clindamycin to AIM RX 3PL, LLC?

AIM RX 3PL, LLC sources Clindamycin from 1 verified supplier: ENCUBE ETHICALS PRIVATE LIMITED ($2.4M, 100.0%). Based on 80 customs records.

Q: How does AIM RX 3PL, LLC compare to other Clindamycin importers?

AIM RX 3PL, LLC ranks #7 among 1,029 Clindamycin importers from India with 3.6% market share and 80 shipments.

Q: Who are the top Clindamycin importers from India?

Top Clindamycin importers: CARDINAL HEALTH ($4.7M), AIM RX 3PL, LLC ($3.3M), EVERSANA LIFE SCIENCE SERVICES ($3.1M), IPD, SC, USA ($3.0M), NORTHSTAR DISTRIBUTION CENTER 8912 ($2.9M).

Suresh Sormare

Clindamycin

India Pharmaceutical Trade Intelligence

$90.2M527 Suppliers144 CountriesHS 30042095

ExportsIndia → UNITED STATES60.9%India → KENYA5.1%

ImportsBELGIUM → India$14.3B FRANCE → India$32.3M

#1 Supplier: ENCUBE ETHICALS #1 Buyer: CARDINAL HEALTH

AIM RX 3PL, LLC — Clindamycin Importer #7 | $2.4M Trade Value | TransData Nexus | TransData Nexus

AIM RX 3PL, LLC — Clindamycin Importer Profile

Pharmaceutical Importer · #7 buyer for Clindamycin · $2.4M import value · 80 shipments · UNITED STATES · DGFT Verified

AIM RX 3PL, LLC is the #7 importer of Clindamycin from India with $2.4M in import value and 80 verified shipments. AIM RX 3PL, LLC holds a 3.6% market share in Clindamycin imports based in UNITED STATES. The company sources from 1 verified supplier across 38 formulations shipped to 1 country. Overall, AIM RX 3PL, LLC imports 4 pharmaceutical products worth $13.4M across 4 therapeutic categories.

AIM RX 3PL, LLC — Clindamycin Import Profile: Suppliers, Formulations & Sources

AIM RX 3PL, LLC — Clindamycin import analysis from Indian Customs (DGFT) data.

Who Actually Supplies Clindamycin to AIM RX 3PL, LLC?

Verified from 80 customs shipment records

Supplier	Value	Shipments	% Share
ENCUBE ETHICALS PRIVATE LIMITED	$2.4M	80	100.0%

AIM RX 3PL, LLC sources Clindamycin from 1 verified Indian supplier based on 80 customs records. The primary supplier is ENCUBE ETHICALS PRIVATE LIMITED accounting for 100.0% of imports.

How Does AIM RX 3PL, LLC Compare to Nearest Clindamycin Importers?

Buyers ranked immediately above and below #7 by import value

#	Buyer	Country

Where Does AIM RX 3PL, LLC Import Clindamycin To?

Destination countries from 80 verified shipments

Country	Value	Shipments	Share
UNITED STATES	$2.4M	80	100.0%

AIM RX 3PL, LLC imports Clindamycin to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $2.4M.

What Clindamycin Formulations Does AIM RX 3PL, LLC Import?

Formulation	Value	Shipments
CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION U	$362.7K	12
CLINDAMYCIN PHOSPHATE TOP. LOT.1% 60ML (	$336.6K	9
CLINDAMYCIN (PHOSPHATE) GEL 1% 30GM (CLI	$156.8K	4
CLINDAMYCIN (PHOSPHATE) GEL 1% 60GM (CLI	$136.7K	4
PRODUCT CODE : FG0002 CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION USP,1% 60ML B.NO.4BH22 TO 4BH25 MFG DATE MAR 2024 EXP DATE	$111.8K	6
CLINDAMYCIN PHOSPHATE TOPICAL LOTION, 1%,60ML B.No.4CW80 AND 4CW82 TO 4CW84 MFGDate MAY 2024 EXP Date APR 2026	$100.0K	2
CLINDAMYCIN(PHOSPHATE)GEL 60 GM BATCH NO.4BG04,4BG06A,4BG05 MFG DT.FEB 2024 EXPDT. JAN 2026	$91.6K	3
CLINDAMYCIN PHOSPHATE GEL 30 GM B.No.4BG21 MFG Date JUN 2024 EXP Date MAY 2026	$77.9K	2
CLINDAMYCIN PHOSPHATE TOP. LOT.1% 60ML,	$50.0K	1
CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION USP,1% 60ML B.No.5BH10 TO 5BH13 MFG DateJAN 2025 EXP Date DEC 2027	$50.0K	1

AIM RX 3PL, LLC imports 38 distinct Clindamycin formulations from India. The top formulation is CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION U with 12 shipments worth $362.7K.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Clindamycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
2.Buyer Identification: AIM RX 3PL, LLC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
4.Market Share: Calculated as AIM RX 3PL, LLC's capped import value divided by total capped export value for Clindamycin across all Indian exporters.
5.Verified Records: This page is backed by 80 individual customs records matching AIM RX 3PL, LLC importing Clindamycin, covering 38 formulations from 1 verified supplier.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 144+ countries, 1,029+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Clindamycin

Clindamycin

AIM RX 3PL, LLC — Clindamycin Importer Profile

AIM RX 3PL, LLC — Clindamycin Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Clindamycin to AIM RX 3PL, LLC?

How Does AIM RX 3PL, LLC Compare to Nearest Clindamycin Importers?

Where Does AIM RX 3PL, LLC Import Clindamycin To?

What Clindamycin Formulations Does AIM RX 3PL, LLC Import?

Regulatory Requirements: Importing Clindamycin into United States

Regulatory Authority

Approval Process for Generic Clindamycin

GMP Requirements

Import Licence & Documentation

Labeling & Packaging

Who Are the Top Buyers of Clindamycin from India and How Much Does AIM RX 3PL, LLC Import?

What Is the Average Order Value for AIM RX 3PL, LLC's Clindamycin Imports?

Who Supplies Clindamycin to AIM RX 3PL, LLC?

How Does AIM RX 3PL, LLC Compare to Other Clindamycin Importers?

About AIM RX 3PL, LLC

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Clindamycin Import Data for AIM RX 3PL, LLC

AIM RX 3PL, LLC × Clindamycin

Company Overview

Top Products by AIM RX 3PL, LLC

Related Analysis

Need Detailed Import Data?

Data Source

1	CARDINAL HEALTH	UNITED STATES	$4.7M	94	$50.0K
7	AIM RX 3PL, LLC ★	UNITED STATES	$3.3M	73	$45.1K
8	EVERSANA LIFE SCIENCE SERVICES	UNITED STATES	$3.1M	84	$36.4K
3	IPD, SC, USA	UNITED STATES	$3.0M	61	$50.0K